Pentoxifylline protects against cerebral ischaemia-reperfusion injury through ferroptosis regulation via the Nrf2/SLC7A11/GPX4 signalling pathway.

Autor: Li P; Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, China; Department of Neurology, Tangshan Gongren Hospital, Tangshan, 063000, Hebei, China., Chen JM; Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, China., Ge SH; Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, China., Sun ML; Department of Neurology, Xingtai People's Hospital, Xingtai, 054001, Hebei, China., Lu JD; Department of Neurology, Baoding First Central Hospital, Baoding, 071000, Hebei, China., Liu F; Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, China., Wang LL; Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, China., Zhang X; Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, China., Wang XP; Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, China. Electronic address: wang__xiaopeng@126.com.
Jazyk: angličtina
Zdroj: European journal of pharmacology [Eur J Pharmacol] 2024 Mar 15; Vol. 967, pp. 176402. Date of Electronic Publication: 2024 Feb 07.
DOI: 10.1016/j.ejphar.2024.176402
Abstrakt: Objective: To investigate whether pentoxifylline (PTX) attenuates cerebral ischaemia-reperfusion injury (IRI) in rats by inhibiting ferroptosis and to explore the underlying molecular mechanisms.
Methods: Cerebral IRI was induced in male Sprague-Dawley (SD) rats using middle cerebral artery occlusion (MCAO). The effects of PTX on cerebral ischaemia-reperfusion brain samples were detected through neurological deficit score, staining and electron microscopy; levels of ferroptosis biomarkers from brain samples were detected using kits. Additionally, the expression levels of nuclear factor erythroid 2-related factor 2 (Nrf2), transferrin receptor protein 1, divalent metal transporter 1, solute carrier family 7 member 11 (SLC7A11) and glutathione peroxidase 4 (GPX4) were determined by immunohistochemistry, real-time quantitative polymerase chain reaction and western blotting.
Results: Pre-treatment with PTX was found to improve neurological function, evidenced by reduced neurological deficit scores, decreased infarct volume and alleviated pathological features post-MCAO. This improvement was accompanied by reduced lipid peroxidation levels and mitigated mitochondrial damage. Notably, PTX's inhibitory effect on ferroptosis was characterised by enhanced Nrf2 nuclear translocation and regulation of ferroptosis-related proteins. Moreover, inhibition of Nrf2 using ML385 (an Nrf2-specific inhibitor) reversed PTX's neuroprotective effect on MCAO-induced ferroptosis via the SLC7A11/GPX4 signalling pathway.
Conclusions: Ferroptosis is evident following cerebral ischaemia-reperfusion in rats. Pentoxifylline confers protection against IRI in rats by inhibiting ferroptosis through the Nrf2/SLC7A11/GPX4 signalling pathway.
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2024 The Second Hospital of Hebei Medical University. Published by Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: